Altered expression of genes regulating angiogenesis in experimental androgen‐independent prostate cancer
Authors:
- 12 December 2007
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 68 (2) , 161-170
Abstract
BACKGROUND: The aim of this study was to investigate how the expression of genes regulating angiogenesis is altered when prostate cancer cells progress into androgen‐independency.METHODS: A gene array specific for angiogenesis was used to compare the human prostate cancer cell line LNCaP (androgen‐dependent) with its more angiogenic and tumorigenic subline LNCaP‐19 (androgen‐independent). Results were verified with real‐time RT‐PCR, and further investigations were focused on the angiogenesis inhibitor a disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1). Expression of ADAMTS1 was investigated in vitro as well as in subcutaneous tumors with real‐time RT‐PCR and Western blotting. Microvessel density (MVD), versican proteolysis and protein levels of TIMP‐2 and TIMP‐3, known as ADAMTS1 inhibitors, were also analyzed in tumor xenografts.RESULTS: The gene array revealed decreased expression of ADAMTS1, ephrin‐A5, fibronectin 1, and neuropilin 1 in LNCaP‐19 compared to LNCaP, while expression of midkine and VEGF were increased. Further studies showed that mRNA and protein levels of ADAMTS1 were significantly lower in LNCaP‐19 compared to LNCaP, both in vitro and in subcutaneous tumors. The amount of ADAMTS1 correlated negatively with MVD, but no relation was found between ADAMTS1 and versican proteolysis.CONCLUSIONS: Expression of several genes associated with angiogenesis was altered during transition into androgen‐independency. Among these, a significant decrease was found for ADAMTS1, whose expression inversely correlated with MVD. Its role in progression of prostate cancer needs further investigation, but this inhibitor of angiogenesis could be an interesting candidate for future anti‐angiogenic therapy. Prostate 68: 161–170, 2008.Keywords
This publication has 36 references indexed in Scilit:
- Vascular endothelial growth factor and angiopoietin are required for prostate regenerationThe Prostate, 2007
- ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2The EMBO Journal, 2006
- Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectivelyOncogene, 2005
- A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesisCytokine & Growth Factor Reviews, 2005
- The expression and regulation of ADAMTS‐1, ‐4, ‐5, ‐9, and ‐15, and TIMP‐3 by TGFβ1 in prostate cells: relevance to the accumulation of versicanThe Prostate, 2005
- Role of ADAMTS-1 in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potentialBiochemical and Biophysical Research Communications, 2004
- ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitorsBiochemical and Biophysical Research Communications, 2002
- VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor bindingJournal of Cellular Biochemistry, 2002
- TESTOSTERONE INDUCES VASCULAR ENDOTHELIAL GROWTH FACTOR SYNTHESIS IN THE VENTRAL PROSTATE IN CASTRATED RATSJournal of Urology, 1999